Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 96 for “"p53 pathway"”.
-
Manipulating the p53 pathway for cancer treatment
p53 is a tumour suppressor that is dysfunctional in most cancers. In some cancers, mutation of the TP53 gene results in expression of a mutant protein or loss of p53 expression, while in others wild-type p53 is retained but there is a defect in the mechanisms that allow for the activation of p53, …
-
Modulation of protein-protein interactions in the p53 pathway
… vast majority of cellular processes. The protein p53 is known as “the guardian of the genome” due to its involvement in DNA repair, inhibition of cell proliferation and cell cycle regulation in general. The activation of p53 is triggered by various stress signals, inducing a negative feedback loop …
-
Mechanisms of regulation of mRNA 3' processing by p53 pathway
Although the p53 network has been intensively studied, genetic analyses long hinted at the existence of components that remained elusive. This dissertation focuses on the study of the regulation of mRNA 3' processing during DNA damage response (DDR) by the p53 pathway and the regulation of p53 …
-
PADI4 REGULATES THE P53 PATHWAY AND TUMOR SUPPRESSION THROUGH CITRULLINATION AND IMMUNE ACTIVATION
TP53 is the most frequently mutated gene in human cancer. While it is well understood that the ability of p53 to act as a transcription factor is required for tumor suppression, the key target genes downstream of p53 required for tumor suppression are still incompletely understood. We first set out …
-
Characterizing apoptotic and transcriptomic effects of novel p53 pathway RNA therapy for high-grade gliomas
… (GBM). This was designed to target the p53 pathway. p53 is a tumour suppressor and the most frequently mutated gene in many cancers. Starting with a bioinformatics study that identified glioma-relevant targets in the p53 pathway, subsequent in vitro cell viability studies were conducted …
-
Identification of negative regulators of p53 pathway by a forward genetic screen in ovarian cancer
… are diagnosed at late stage ovarian cancer. TP53 is the most commonly mutated gene in ovarian cancer as well as in all other cancers. However, there are subsets of ovarian cancer patients with wild-type TP53, and we would like to understand the molecular and cellular mechanisms that disable …
-
GENOMIC AND FUNCTIONAL CHARACTERIZATION OF THE P53 PATHWAY IN RELATION TO 17P13 (DEL) IN MULTIPLE MYELOMA
Hemizygous deletion of 17p13, which harbors the TP53 gene, has been identified in up to 20% of newly diagnosed multiple myeloma (MM) patients and is associated with poor prognosis. To date, there is no conclusive evidence that TP53 is the critical gene. Furthermore, the functional effect of TP53 …
-
Computational design of protein-protein interactions to engineer novel inhibitors of the p53 pathway and the polycomb repressive complex
Here I present 2 examples of the application of the Rosetta macromolecular modeling software suite to the successful development of novel protein-based inhibitors with the aim of creating useful tools for the greater cancer research community. Rosetta was used to engineer the first examples of high …
-
The identification and analysis of molecular biomarkers in the p53 tumour suppressor pathway that affect cancer progression in humans
<p>The tumour suppressor p53 is at the centre of the signalling pathway that controls cellular processes crucial in tumourogenesis, cancer progression and tumour clearance. Alterations in the p53 pathway that lead to cancer progression can be good candidates for molecular biomarkers that would …
-
Computational Design of Protein Pathway Inhibitors
… This concept is extremely significant in the p53 interaction network. When disease states occur in the p53 network, it is a leading cause of cancer. A deeper understanding of how the PPI networks shift in the presence of disruptions is needed in order to understand how disease states can arise …
-
Evaluation of Novel Diketones as Anti-cancer Agents
… some mammalian cancer cells. On the other hand, p53 tumour suppressor is a DNA damage inducible transcription factor mutated in over half of human cancers. The aim of this study is to analyse the effects of DBM derivatives on osteosarcoma, mesothelioma and lung cancer cell lines and correlate it …
-
Μελέτη αντιοξειδωτικής και φωτοπροστατευτικής δράσης φυσικών προϊόντων
… damage and lead to a delayed activation of ATM-p53 pathway. Using specific inhibitors, it was shown that the activation of Akt and of JNKs, in particular are necessary for the protection of fibroblasts from UVB. Akt activation is due to the epidermal growth factor receptor (EGFR). In addition, …
-
TRANSCRIPTOMIC AND FUNCTIONAL ANALYSIS OF THE ANTIVIRAL EFFECTS OF ESTRADIOL ON HSV-2 INFECTION IN HUMAN VAGINAL EPITHELIAL CELLS
… was performed to identify potential cellular pathways regulated by E2 after infection using the Hallmark database, relative to NH conditions. Immunofluorescence staining was used for functional analysis to confirm transcriptomic data. After selecting a pathway for investigation, small-molecule …
-
Wip1 regulates proliferation of adult neural progenitors through P53 dependent G2 cell cycle control
… suggested that Wip1 regulates NPCs through p53, which are the phosphorylation level of p53 was up-regulated in Wip1 ko NPCs in vivo and in vitro, and transcriptions of p21 and Reprimo was p53-dependent in NPCs. Furthermore, the impaired M-phase entry and amplification of Wip1-null NPCs were …
-
p14ARF : A p53-Independent Tumor Suppressor
… in tumor surveillance. Breakdowns in the p14 pathway have been estimated to be present in approximately 40% of human cancers and only recently have its binding partners and effects begun to be defined. Its interaction with the p53 pathway, which is estimated to be inactivated or mutated in 50% …
-
Chemical biology approaches for the identification of novel p53 regulatory signalling pathways.
p53 is a critical tumour suppressor which acts to repair or remove abnormal cells and thus prevent cancer. Aberrant function of p53 is therefore a critical step in tumourigenesis and p53 is mutated in half of all cancers. Mutation of p53 leads to both a loss of normal wildtype function as well as …
-
Influence of Estradiol and Phytoestrogens on Colitis and Colon Cancer
… the interaction of estrogen signaling and the p53 pathway was studied using intestinal epithelial cell-specific p53 knockout mice (Tp53^ΔIEC). The protective effect of E2 in Tp53^ΔIEC mice was observed, suggesting that the suppression of ACF by estrogen signaling is partially independent of the …
Page 1 of 5